Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment

Severe eosinophilic asthma is characterized by chronic airway inflammation, oxidative stress, and elevated proinflammatory cytokines, especially IL-5. Mepolizumab and benralizumab are both humanized IgG antibodies directed against IL-5 signaling, directly acting on eosinophils count. Together with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vantaggiato, Lorenza, Cameli, Paolo, Bergantini, Laura, d’Alessandro, Miriana, Shaba, Enxhi, Carleo, Alfonso, Di Giuseppe, Fabrizio, Angelucci, Stefania, Sebastiani, Guido, Dotta, Francesco, Bini, Luca, Bargagli, Elena, Landi, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027545/
https://www.ncbi.nlm.nih.gov/pubmed/35453511
http://dx.doi.org/10.3390/biomedicines10040761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027545/
https://www.ncbi.nlm.nih.gov/pubmed/35453511
http://dx.doi.org/10.3390/biomedicines10040761

Ejemplares similares